RPX’s CEO released a statement on our response to the COVID-19 emergency. Click here to access.

RPX’s CEO released a statement on our response to the COVID-19 emergency. Click here to access.

Transcutaneous analyte sensor

  • US 7,905,833 B2
  • Filed: 06/21/2005
  • Issued: 03/15/2011
  • Est. Priority Date: 07/13/2004
  • Status: Active Grant
  • ×

    Create Patent Alert


    *Certain alert events are not available for your current subscription level. Upgrade
  • Save